The therapy with cannabinoids in the treatment of cerebral tumors involves (intracranial or systematic) administration of (natural or synthetic) cannabinoids to (human or non-human) mammals having cerebral tumors. Activation of the specific receptors of the cannabinoids leads to selective death of the transformed cells. Regression or eradication of the cerebral tumors is achieved without any significant side-effects.